US Broker Ratings

Envista Holdings (NVST) Stock Analysis: Navigating Challenges with Strategic Solutions

Envista Holdings Corporation (NYSE: NVST), a key player in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing investor attention with its..

GeneDx Holdings Corp. (WGS) Stock Analysis: A 20.96% Upside Potential in the Genomics Revolution

GeneDx Holdings Corp. (NASDAQ: WGS) stands out in the healthcare sector, particularly within the diagnostics and research industry, as a key player in the genomics field...

Metsera, Inc. (MTSR) Stock Analysis: Strong Buy Ratings and Nearly 94% Upside Potential

Metsera, Inc. (NASDAQ: MTSR) stands out in the biotechnology sector with a compelling growth narrative driven by cutting-edge research in treating obesity and related diseases. Founded..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Navigating a Potential 89% Upside in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is making waves in the healthcare sector with its specialized focus on outpatient mental health services. Headquartered in Scottsdale, Arizona,..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Evaluating a Potential 13.82% Upside Amidst Sector Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a stalwart in the medical instruments and supplies sector, presents an intriguing opportunity for investors willing to navigate the complexities of..

Kymera Therapeutics (KYMR): Analyst Consensus Points to a Potential 39% Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company headquartered in Watertown, Massachusetts, is turning heads in the biotechnology sector with its innovative approach to drug..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Compelling 64.86% Upside Amidst Biotech Innovation

MoonLake Immunotherapeutics (NASDAQ: MLTX), a promising entrant in the biotechnology sector, is capturing investor attention with its innovative approach to treating inflammatory diseases. This Switzerland-based company,..

Apellis Pharmaceuticals (APLS) Stock Analysis: Potential 102.93% Upside as Biotech Innovates in High Unmet Need Areas

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent player in the biotechnology sector, stands out as a commercial-stage biopharmaceutical company dedicated to developing novel therapeutic compounds aimed..

Premier, Inc. (PINC) Stock Analysis: Understanding the Healthcare Titan’s Dividend Yield and Growth Challenges

Premier, Inc. (NASDAQ: PINC), a prominent player in the healthcare sector, has carved a niche in the health information services industry. With a market capitalization of..

Scholar Rock Holding Corporation (SRRK): Biotech Potential with Nearly 40% Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK), a Cambridge-based biopharmaceutical company, is making significant strides in the biotechnology sector. With a market capitalization of $3.37 billion, Scholar..

Ligand Pharmaceuticals (LGND) Stock Analysis: Potential Upside and Strategic Growth in Biotechnology

Ligand Pharmaceuticals Inc. (NASDAQ: LGND), a prominent player in the biotechnology sector, has been capturing investor attention with its robust growth prospects and strategic initiatives. As..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 50% Potential Upside in the Healthcare Sector

Vericel Corporation (NASDAQ: VCEL) has become an intriguing contender in the healthcare and biotechnology sectors, not just for its innovative cellular therapies but also for its..

Organon & Co. (OGN) Stock Analysis: A 44% Potential Upside in the Healthcare Sector

In a volatile market landscape, Organon & Co. (NYSE: OGN) presents an intriguing opportunity for investors with a potential upside of 44.03%, according to recent analyst..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 36.50% Upside Potential Amidst Healthcare Sector Volatility

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, presents a compelling investment opportunity..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: A 228% Potential Upside for This Biotech Play

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising portfolio of novel therapies targeting metabolic and..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth with a 3.62% Upside

Warby Parker Inc. (NYSE: WRBY) operates at the intersection of healthcare and fashion, carving out a niche in the medical instruments and supplies industry with its..

ImmunityBio, Inc. (IBRX) Stock Analysis: Uncovering a 319% Potential Upside in Biotech Innovation

ImmunityBio, Inc. (NASDAQ: IBRX), a pioneering force in the biotechnology sector, is attracting significant attention with its cutting-edge therapies aimed at enhancing the immune system’s ability..

Mirum Pharmaceuticals (MIRM) Investor Outlook: Unpacking a 35.92% Potential Upside and Robust Revenue Growth

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the biotechnology sector, captivating investor interest with its promising potential upside and robust revenue growth. As a..

SpringWorks Therapeutics, Inc. (SWTX): An Investor Outlook on the Biotech Innovator with a 133.70% Revenue Growth

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), a prominent player in the biotechnology sector, is making waves with its rapid revenue growth and innovative approach to treating rare..

Crinetics Pharmaceuticals (CRNX): A Biotech Leader with 150% Upside Potential and Strong Buy Ratings

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands out in the biotechnology sector with its focus on discovering and developing novel therapeutics for rare endocrine diseases and endocrine-related..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds